Prevalence and natural course of gastroesophageal reflux disease

被引：12
作者：
Labenz J. [1 ]
Labenz C. [2 ]
机构：
[1] Diakonie Klinikum – Jung-Stilling-Krankenhaus, Wichernstr. 40, Siegen
[2] Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen, Essen
来源：
Der Gastroenterologe | 2016年 / 11卷 / 2期
关键词：
Barrett‘s carcinoma; Barrett‘s esophagus; Endoskopy; Epidemiology; Gastroesophageal reflux disease;
D O I：
10.1007/s11377-016-0045-0
中图分类号：
学科分类号：
摘要：
Background: The epidemiology of a disease, in particular the natural course, is important for treatment planning and monitoring strategies. Objective: Incidence, prevalence, and natural course of gastroesophageal reflux disease (GERD). Materials and methods: Selective literature search in the database PubMed. Results: In industrialized countries, approximately 20 % of adults suffer from symptomatic GERD. In addition, asymptomatic esophageal reflux and Barrett esophagus was observed in more than 5 % of the general public in an endoscopic population based study. Spontaneous healing of GERD does occur, but in the majority of cases the disease is chronic. GERD is not a categorical disease. Approximately 25–30 % of patients have endoscopic progression of their disease over time. The cancer risk of Barrett esophagus is estimated to be 0.1–0.15 % per year, which is less than originally assumed. Overall, GERD is not associated with a shortened life expectancy. The epidemiology of extra-esophageal symptoms is largely unknown. Conclusion: GERD is a common disease with a good prognosis with regard to survival. Spontaneous recovery occurs as well as progression of endoscopic lesions. The cancer risk of Barrett esophagus is lower than expected; thus, surveillance should be limited to high-risk patients. © 2016, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码：102 / 109
页数：7
相关论文
共 44 条
  • [31] Pace F., Bianchi Porro G., Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed), Am J Gastroenterol, 99, pp. 946-949, (2004)
  • [32] Pohl H., Pech O., Arash H., Et al., Length of Barrett´s oesophagus and cancer risk: implications from a large sample of patients with early adenocarcinoma, Gut, 65, pp. 196-201, (2015)
  • [33] Pohl H., Wrobel K., Bojarski C., Et al., Risk factors in the development of esophageal adenocarcinoma, Am J Gastroenterol, 108, pp. 200-207, (2013)
  • [34] Ronkainen J., Aro P., Storskrubb T., Et al., High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult population: a Kalixanda study report, Scand J Gastroenterol, 40, pp. 275-285, (2005)
  • [35] Ronkainen J., Aro P., Storskrubb T., Et al., Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population – the Kalixanda study, Aliment Pharmacol Ther, 23, pp. 1725-1733, (2006)
  • [36] Ronkainen J., Aro P., Storskrubb T., Et al., Prevalence of Barrett´s esophagus in the general population: an endoscopic study, Gastroenterology, 129, pp. 1825-1831, (2005)
  • [37] Ronkainen J., Talley N.J., Storskrubb T., Et al., Erosive esophagitis is a risk factor for Barrett´s esophagus: a community based endoscopic follow-up study, Am J Gastroenterol, 106, pp. 1946-1952, (2011)
  • [38] Ruigomez A., Wallander M.A., Lundborg P., Et al., Gastroesophageal reflux disease in children and adolescents in primary care, Scand J Gastroenterol, 45, pp. 139-146, (2010)
  • [39] Savarino E., Pohl D., Zentilin P., Et al., Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease, Gut, 58, pp. 1185-1191, (2009)
  • [40] Solaymani-Dodaran M., Card T.R., West J., Cause-specific mortality of people with Barrett´s esophagus compared with the general population: a population-based cohort study, Gastroenterology, 144, pp. 1375-1383, (2013)
12345